MBRX
MBRX
NASDAQ · Biotechnology

Moleculin Biotech Inc

$4.31
+0.40 (+10.23%)
As of Feb 8, 2:27 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.53M 2.25M 2.34M
Net Income -604,093 -536,841 -566,432
EPS
Profit Margin -23.9% -23.9% -24.2%
Rev Growth -6.1% -2.1% -7.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 4.62M 5.29M 5.47M
Total Equity 9.01M 8.31M 8.07M
D/E Ratio 0.51 0.64 0.68
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -828,287 -680,626 -721,197
Free Cash Flow -326,986 -310,260 -424,378